Global Biologics and Biosimilars Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Biologics and Biosimilars Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Interferon
  • 1.2.4 Erythropoietin
  • 1.2.5 Insulin
  • 1.2.6 Vaccines
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application
  • 1.3.2 Tumor
  • 1.3.3 Diabetes
  • 1.3.4 Cardiovascular
  • 1.3.5 Hemophilia
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Biologics and Biosimilars Sales Estimates and Forecasts 2016-2027
• 2.2 Global Biologics and Biosimilars Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Biologics and Biosimilars Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Biologics and Biosimilars Regions by Sales
  • 2.4.1 Global Top Biologics and Biosimilars Regions by Sales (2016-2021)
  • 2.4.2 Global Top Biologics and Biosimilars Regions by Sales (2022-2027)
• 2.5 Global Top Biologics and Biosimilars Regions by Revenue
  • 2.5.1 Global Top Biologics and Biosimilars Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Biologics and Biosimilars Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Biologics and Biosimilars Sales by Manufacturers
  • 3.1.1 Global Top Biologics and Biosimilars Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Biologics and Biosimilars Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Sales in 2020
• 3.2 Global Biologics and Biosimilars Revenue by Manufacturers
  • 3.2.1 Global Top Biologics and Biosimilars Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Biologics and Biosimilars Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2020
• 3.3 Global Biologics and Biosimilars Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Biologics and Biosimilars Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Biologics and Biosimilars Sales by Type
  • 4.1.1 Global Biologics and Biosimilars Historical Sales by Type (2016-2021)
  • 4.1.2 Global Biologics and Biosimilars Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Biologics and Biosimilars Sales Market Share by Type (2016-2027)
• 4.2 Global Biologics and Biosimilars Revenue by Type
  • 4.2.1 Global Biologics and Biosimilars Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Biologics and Biosimilars Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Biologics and Biosimilars Revenue Market Share by Type (2016-2027)
• 4.3 Global Biologics and Biosimilars Price by Type
  • 4.3.1 Global Biologics and Biosimilars Price by Type (2016-2021)
  • 4.3.2 Global Biologics and Biosimilars Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Biologics and Biosimilars Sales by Application
  • 5.1.1 Global Biologics and Biosimilars Historical Sales by Application (2016-2021)
  • 5.1.2 Global Biologics and Biosimilars Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Biologics and Biosimilars Sales Market Share by Application (2016-2027)
• 5.2 Global Biologics and Biosimilars Revenue by Application
  • 5.2.1 Global Biologics and Biosimilars Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Biologics and Biosimilars Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Biologics and Biosimilars Revenue Market Share by Application (2016-2027)
• 5.3 Global Biologics and Biosimilars Price by Application
  • 5.3.1 Global Biologics and Biosimilars Price by Application (2016-2021)
  • 5.3.2 Global Biologics and Biosimilars Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Biologics and Biosimilars Market Size by Type
  • 6.1.1 North America Biologics and Biosimilars Sales by Type (2016-2027)
  • 6.1.2 North America Biologics and Biosimilars Revenue by Type (2016-2027)
• 6.2 North America Biologics and Biosimilars Market Size by Application
  • 6.2.1 North America Biologics and Biosimilars Sales by Application (2016-2027)
  • 6.2.2 North America Biologics and Biosimilars Revenue by Application (2016-2027)
• 6.3 North America Biologics and Biosimilars Market Size by Country
  • 6.3.1 North America Biologics and Biosimilars Sales by Country (2016-2027)
  • 6.3.2 North America Biologics and Biosimilars Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Biologics and Biosimilars Market Size by Type
  • 7.1.1 Europe Biologics and Biosimilars Sales by Type (2017-2027)
  • 7.1.2 Europe Biologics and Biosimilars Revenue by Type (2017-2027)
• 7.2 Europe Biologics and Biosimilars Market Size by Application
  • 7.2.1 Europe Biologics and Biosimilars Sales by Application (2017-2027)
  • 7.2.2 Europe Biologics and Biosimilars Revenue by Application (2017-2027)
• 7.3 Europe Biologics and Biosimilars Market Size by Country
  • 7.3.1 Europe Biologics and Biosimilars Sales by Country (2017-2027)
  • 7.3.2 Europe Biologics and Biosimilars Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Biologics and Biosimilars Market Size by Type
  • 8.1.1 Asia Pacific Biologics and Biosimilars Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Biologics and Biosimilars Revenue by Type (2018-2027)
• 8.2 Asia Pacific Biologics and Biosimilars Market Size by Application
  • 8.2.1 Asia Pacific Biologics and Biosimilars Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Biologics and Biosimilars Revenue by Application (2018-2027)
• 8.3 Asia Pacific Biologics and Biosimilars Market Size by Region
  • 8.3.1 Asia Pacific Biologics and Biosimilars Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Biologics and Biosimilars Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Biologics and Biosimilars Market Size by Type
  • 9.1.1 Latin America Biologics and Biosimilars Sales by Type (2019-2027)
  • 9.1.2 Latin America Biologics and Biosimilars Revenue by Type (2019-2027)
• 9.2 Latin America Biologics and Biosimilars Market Size by Application
  • 9.2.1 Latin America Biologics and Biosimilars Sales by Application (2019-2027)
  • 9.2.2 Latin America Biologics and Biosimilars Revenue by Application (2019-2027)
• 9.3 Latin America Biologics and Biosimilars Market Size by Country
  • 9.3.1 Latin America Biologics and Biosimilars Sales by Country (2019-2027)
  • 9.3.2 Latin America Biologics and Biosimilars Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Biologics and Biosimilars Market Size by Type
  • 6.1.1 Middle East and Africa Biologics and Biosimilars Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Biologics and Biosimilars Market Size by Application
  • 6.2.1 Middle East and Africa Biologics and Biosimilars Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Biologics and Biosimilars Market Size by Country
  • 6.3.1 Middle East and Africa Biologics and Biosimilars Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Biologics and Biosimilars Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Biologics and Biosimilars Product Description
  • 11.1.5 Roche Related Developments
• 11.2 Amgen
  • 11.2.1 Amgen Corporation Information
  • 11.2.2 Amgen Overview
  • 11.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Amgen Biologics and Biosimilars Product Description
  • 11.2.5 Amgen Related Developments
• 11.3 AbbVie
  • 11.3.1 AbbVie Corporation Information
  • 11.3.2 AbbVie Overview
  • 11.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 AbbVie Biologics and Biosimilars Product Description
  • 11.3.5 AbbVie Related Developments
• 11.4 Sanofi-Aventis
  • 11.4.1 Sanofi-Aventis Corporation Information
  • 11.4.2 Sanofi-Aventis Overview
  • 11.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Sanofi-Aventis Biologics and Biosimilars Product Description
  • 11.4.5 Sanofi-Aventis Related Developments
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Corporation Information
  • 11.5.2 Johnson & Johnson Overview
  • 11.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Johnson & Johnson Biologics and Biosimilars Product Description
  • 11.5.5 Johnson & Johnson Related Developments
• 11.6 Pfizer
  • 11.6.1 Pfizer Corporation Information
  • 11.6.2 Pfizer Overview
  • 11.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Pfizer Biologics and Biosimilars Product Description
  • 11.6.5 Pfizer Related Developments
• 11.7 Novo Nordisk
  • 11.7.1 Novo Nordisk Corporation Information
  • 11.7.2 Novo Nordisk Overview
  • 11.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Novo Nordisk Biologics and Biosimilars Product Description
  • 11.7.5 Novo Nordisk Related Developments
• 11.8 Eli Lilly
  • 11.8.1 Eli Lilly Corporation Information
  • 11.8.2 Eli Lilly Overview
  • 11.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Eli Lilly Biologics and Biosimilars Product Description
  • 11.8.5 Eli Lilly Related Developments
• 11.9 Novartis
  • 11.9.1 Novartis Corporation Information
  • 11.9.2 Novartis Overview
  • 11.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Novartis Biologics and Biosimilars Product Description
  • 11.9.5 Novartis Related Developments
• 11.10 Merck
  • 11.10.1 Merck Corporation Information
  • 11.10.2 Merck Overview
  • 11.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Merck Biologics and Biosimilars Product Description
  • 11.10.5 Merck Related Developments
• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Biologics and Biosimilars Product Description
  • 11.1.5 Roche Related Developments
• 11.12 Changchun High Tech
  • 11.12.1 Changchun High Tech Corporation Information
  • 11.12.2 Changchun High Tech Overview
  • 11.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Changchun High Tech Product Description
  • 11.12.5 Changchun High Tech Related Developments
• 11.13 CP Guojian
  • 11.13.1 CP Guojian Corporation Information
  • 11.13.2 CP Guojian Overview
  • 11.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 CP Guojian Product Description
  • 11.13.5 CP Guojian Related Developments
• 11.14 Biotech
  • 11.14.1 Biotech Corporation Information
  • 11.14.2 Biotech Overview
  • 11.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Biotech Product Description
  • 11.14.5 Biotech Related Developments
• 11.15 Gelgen
  • 11.15.1 Gelgen Corporation Information
  • 11.15.2 Gelgen Overview
  • 11.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Gelgen Product Description
  • 11.15.5 Gelgen Related Developments
• 11.16 Innovent
  • 11.16.1 Innovent Corporation Information
  • 11.16.2 Innovent Overview
  • 11.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Innovent Product Description
  • 11.16.5 Innovent Related Developments
• 11.17 Dong Bao
  • 11.17.1 Dong Bao Corporation Information
  • 11.17.2 Dong Bao Overview
  • 11.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Dong Bao Product Description
  • 11.17.5 Dong Bao Related Developments
• 11.18 Ganlee
  • 11.18.1 Ganlee Corporation Information
  • 11.18.2 Ganlee Overview
  • 11.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.18.4 Ganlee Product Description
  • 11.18.5 Ganlee Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Biologics and Biosimilars Value Chain Analysis
• 12.2 Biologics and Biosimilars Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Biologics and Biosimilars Production Mode & Process
• 12.4 Biologics and Biosimilars Sales and Marketing
  • 12.4.1 Biologics and Biosimilars Sales Channels
  • 12.4.2 Biologics and Biosimilars Distributors
• 12.5 Biologics and Biosimilars Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Biologics and Biosimilars Industry Trends
• 13.2 Biologics and Biosimilars Market Drivers
• 13.3 Biologics and Biosimilars Market Challenges
• 13.4 Biologics and Biosimilars Market Restraints

14 Key Findings in The Global Biologics and Biosimilars Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details